THERAPIX BIOSCIENCES LTD's ticker is TRPXY and the CUSIP is 88339A203. A total of 3 filers reported holding THERAPIX BIOSCIENCES LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $271,000 | +5320.0% | 436,189 | +3682.1% | 0.00% | – |
| Q1 2020 | $5,000 | +150.0% | 11,533 | +667.3% | 0.00% | – |
| Q4 2019 | $2,000 | -66.7% | 1,503 | -35.8% | 0.00% | – |
| Q3 2019 | $6,000 | -76.9% | 2,340 | -77.1% | 0.00% | – |
| Q2 2019 | $26,000 | -76.1% | 10,205 | -70.8% | 0.00% | – |
| Q1 2019 | $109,000 | -31.9% | 34,916 | -29.2% | 0.00% | – |
| Q4 2018 | $160,000 | +370.6% | 49,338 | +525.3% | 0.00% | – |
| Q3 2018 | $34,000 | -12.8% | 7,890 | -17.7% | 0.00% | – |
| Q2 2018 | $39,000 | -25.0% | 9,587 | +5.2% | 0.00% | – |
| Q1 2018 | $52,000 | -3.7% | 9,117 | -9.9% | 0.00% | – |
| Q4 2017 | $54,000 | -8.5% | 10,117 | -1.3% | 0.00% | – |
| Q3 2017 | $59,000 | -25.3% | 10,250 | -8.9% | 0.00% | – |
| Q2 2017 | $79,000 | -80.1% | 11,250 | -77.0% | 0.00% | – |
| Q1 2017 | $396,000 | – | 48,924 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|